Syva collaborates in the 53rd edition of SEPOR
On 26th and 29th October, we collaborated with SEPOR, the feria livestock, industrial and agri-food fair.
Although the 53rd edition was held in Lorca, all the content was adapted to a ‘virtual setting’ as a consequence of the coronavirus pandemic. This meant that interested parties could follow its scientific, technical and commercial programme from anywhere in the world.
Of the various and interesting talks that took place, we highlight the talk by our swine technician, Álvaro Aguarón, who tackled the problem of swine erysipelas in white pigs under the title “Red on white”.
Álvaro clearly and concisely explained that red disease is, apart from a disease that afflicts pigs, a public health problem and a professional responsibility. Major importance is given to control strategies such as vaccination.
Once again, thank you for having taken part in this fair. We did not want to let the professionals down, giving a clear example of reinvention during this crisis.
Discover more
Video of our swine technician, Álvaro Aguarón: “Red on white”
You may also be interested in
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.